IPSC Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for IPSC (IPSC) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| OSTX OS Therapies Incorporated | $1.39 +5.30% |
| CUE Cue Biopharma, Inc. | $0.44 -7.26% |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $1.31 +0.77% |
| SNTI Senti Biosciences, Inc. | $0.93 +2.98% |
| COEP Coeptis Therapeutics, Inc. | $12.44 +2.81% |
| S SentinelOne, Inc. | $12.75 -0.31% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| OSTX OS Therapies Incorporated | $1.39 | +5.30% | 56.24 M | -1.42 | -0.98 | 0.00% | Buy | 632 |
| CUE Cue Biopharma, Inc. | $0.44 | -7.26% | 34.53 M | -1.56 | -0.28 | 0.00% | Buy | 7.27 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $1.31 | +0.77% | 45.04 M | -3.97 | -0.33 | 0.00% | Hold | 213 |
| SNTI Senti Biosciences, Inc. | $0.93 | +2.98% | 24.41 M | -0.34 | -2.75 | 0.00% | Buy | 76 |
| COEP Coeptis Therapeutics, Inc. | $12.44 | +2.81% | 43.71 M | -4.43 | -2.81 | 0.00% | Hold | 22 |
| S SentinelOne, Inc. | $12.75 | -0.31% | 4.26 B | -9.31 | -1.37 | 0.00% | Buy | 8.05 |
Frequently Asked Questions
What are IPSC's latest financial results?
Review IPSC's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has IPSC's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is IPSC's cash flow situation and liquidity?
Cash flow statements reveal how IPSC generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does IPSC's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether IPSC is outperforming or lagging within its sector.
Are IPSC's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether IPSC's profits are repeatable and supported by strong fundamentals.